bullish

Genscript Biotech (1548.HK) 22H1 - The Outlook and the Risks Behind

235 Views14 Sep 2022 08:47
If seen from the business level, GenScript has investment value,with high growth potential in valuation. The biggest worry is "black swan event". We don't know what “surprises” GenScript will bring us
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
x